Researcher Spotlight- Professor Josephine Forbes 8 October 2015 Glucose transport in the diabetic kidney Professor Josephine Forbes, Dr Lindo Gallo and team at the University of Queensland are conducting research on the discovery of new pathways to combat diabetes and kidney disease. Specifically how glucose is absorbed and moved around within the kidneys in diabetes. “This research is important because a new class of therapy to lower blood glucose levels, called SGLT2 inhibitors, has recently become available for individuals with type 2 diabetes,†says Professor Forbes. “This therapy works specifically in the kidney to encourage the excretion of glucose into the urine, which therefore reduces the levels in the bloodstream. “Our research aims to improve the way we therapeutically target the kidney to improve blood glucose levels and also provide clues as to why the kidneys are commonly affected in individuals with diabetes. “Funding from Diabetes Australia is absolutely critical in allowing us to perform this research. The financial support contributes to the cost of research consumables, infrastructure, and staff salaries. Through our combined research effort and support from Diabetes Australia, we hope to contribute to efforts to improve lives for all individuals with diabetes and kidney disease.†Prof Josephine Forbes is a senior researcher at Mater Research Institute, Dr Linda Gallo is an Honorary Fellow at Mater Research Institute.
Partners 27 August 2025 Glucerna is clinically shown to help manage weight while protecting muscle in diabetes*1 advertisement Managing your weight can help prevent or manage diabetes If you’ve been diagnosed with pre-diabetes, losing just 5–10% of your... Continue Reading
Media releases 27 August 2025 Diabetes in General Practice Research Grant Awarded The recipients of the 2025 Australian General Practice Research Foundation/Diabetes Australia Research Grant have been announced today, with the funding... Continue Reading
Media releases 20 August 2025 Diabetes Australia and Medibank partner in research to prevent type 2 diabetes Diabetes Australia has announced a new partnership with health company Medibank to support life changing research into type 2 diabetes... Continue Reading